Regeneron

Why is this trending?

President Trump announced a drug pricing deal with Regeneron Pharmaceuticals to offer prescriptions at most-favored-nation prices and provide their new FDA-approved gene therapy for rare hearing loss free to U.S. patients. The agreement aligns U.S. prices with the lowest global rates as part of a White House initiative to lower healthcare costs.